While investigating the molecular mechanisms responsible for EPHB2 inactivation in CRC, some authors have indicated that reduced EphB2 expression in a subset of CRC cases could be attributed to DNA methylation (47, 70, 71). The gene discussed is EPHB2; the disease is colorectal carcinoma.